ADPT News and Press, Adaptive Biotechnologies Corporation From 02/06/26

2026-02-06 12:15:23 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript Adaptive Biotechnologies Corporation 2025 Q4 - Results - Earnings Call Presentation Adaptive Biotechnologies Corporation (ADPT) Presen...

2026-02-05 21:07:36 ET Image source: The Motley Fool. Feb. 5, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-05 16:15:31 ET More on Adaptive Biotechnologies Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Tra...

SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat diseas...

Exponent Inc. (EXPO) is expected to report $0.47 for Q4 2025 Peabody Energy Corporation (BTU) is expected to report $0.08 for Q4 2025 Affirm Holdings Inc. (AFRM) is expected to report $0.28 for Q2 2026 Power Integrations Inc. (POWI) is expected to report $0.03 for Q4 2025 Alpha an...

SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial...

2026-01-12 22:35:58 ET Adaptive Biotechnologies Corporation (ADPT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 7:30 PM EST... Read the full article on Seeking Alpha For further details see: Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annua...

2026-01-12 07:50:26 ET More on Adaptive Biotechnologies Adaptive Biotechnologies: 2026 Is The Durability Test, Not The Hype Cycle Adaptive Biotechnologies Corporation 2025 Q3 - Results - Earnings Call Presentation Adaptive Biotechnologies Corporation (ADPT) Q3 2025 E...

SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced preliminary, unaudited r...

SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating...